Uranium Royalty Corp. (UROY) — RQD Stock Rating Cockpit

$3.35 -3.46% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $3.32

Uranium Royalty Corp. (UROY) carries a Roarable Rating of D+ (Sell) with 54/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D+ • SELL / AVOID Cap $1.31B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on UROY Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is UROY stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-02, Uranium Royalty Corp. (NASDAQ: UROY) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 54/100 at a spot price of $3.35 (-3.46% 1D, market cap $1.31B). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 4/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 14/20. Across 1096 tracked Financials issuers, UROY ranks #582 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does UROY compare to MUA and BKT in the Financials sector?
▼

Within the Financials sector (Investment Bankers/Brokers/Service), UROY carries a Roarable D+ (54/100 RQD), trailing P/E of 32.5x, gross margin of —, and ROIC of —. By comparison, MUA (Blackrock MuniAssets Fund Inc) holds a D grade (47/100 RQD, P/E N/A, ROIC —, cap $1.45B) and BKT (BlackRock Income Trust Inc.) posts a D grade (47/100 RQD, P/E N/A, ROIC —, cap $1.47B). Among the 5-stock peer group, OPY leads on earnings multiple (7.8x) while OPY leads on capital efficiency (17.6% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for UROY?
▼

Per UROY's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-04-30, CIK 0002143673), Uranium Royalty Corp. generated $0 in revenue, $40.2M in net income, and $178.5M in free cash flow against $0 in total assets and $0 in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $3.32 (-0.81%)🧬 Cannibal Buyback (-1.80% YoY Shares)⚙️ Cash Engine: 14/20 (B-) • 4.5% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 54/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.7% avg 90D alpha vs SPY • 51.0% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →
RQD QUANT TACHOMETERSELL / AVOID • D+
025507510054
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk D+
Cash (14)Whales (4)SEC (13)Macro (9)CEO (14)
Each axis scored 0–20
12M PRICE TARGET CONE-1.8% Base Target
$6 Bull$3 Base$3 Bear
📬 FREE UROY RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for UROY)Realized 20D OHLCV Swing Band: ±9.9%
Deterministic 5-Pillar Attribution (54/100 Composite)
🔍 WHY UROY SCORES 54/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Cash Engine Quality+14/20 pts (26% of score)

SEC XBRL FY 2025 (10-K): 4.5% FCF Margin ($178.5M FCF) & 52% Gross Margin

▲ #2 Bullish Driver: Insider Conviction & Share Dilution+14/20 pts (26% of score)

SEC Form 4 / 13F Thermometer: 70% Net Buy • Cannibal Buyback (-1.80% YoY Shares)

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
62
Grade C+$3.99-12.3% Next Q
Q2 (-2Q)
59
Grade C$3.50-2.9% Next Q
Q3 (-1Q)
57
Grade C$3.40-1.5% Next Q
Current
54
Grade D+$3.35-0.7% Hist 90D α
Trajectory: C+ (62) → D+ (54)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a UROY Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While UROY currently carries a cautious 54/100 (D+) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Company leadership has skin in the game with net positive insider conviction.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($4.06) and Max Pain ($3.52) forces dealer call-delta covering toward $5.80.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Cannibal Buyback (-1.80% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $UROY• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “UROY Beats Next Quarter EPS Consensus (Jan 28, 2027) & Holds Above 200D SMA”
RSI-14 MOMENTUMNEUTRAL RANGE
41.230 Oversold · 70 Hot
ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)
3.80>3.0 Fortress Safe
PIOTROSKI F-SCORESOLID CORE (5–6)
5 / 99-Pt Accounting
52-WEEK LASER RANGE27% OF RANGE
L: $3$3.35H: $6
1. Money & Cash Health● MIXED
Are profits real cash in the bank?

Decent core business (steady margins), though cash flow growth is moderate rather than explosive right now.

Factor Grade: B-RQD 14 / 20
2. Big Money & Insiders● TRIMMING
Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: DRQD 18 / 40
3. Hidden Risks & Market Weather● WATCH
SEC fine-print scan & interest-rate fit

No major SEC filing blowups, though current interest rates and Fed liquidity call for normal position sizing.

Factor Grade: D+RQD 22 / 40
MULTI-MODEL JEV QUANT JURY DELIBERATION

JEV AI Jury Split (Battleground) on UROY

Cash & Moat Bull AI
ROIC & Free Cash Flow Model
BULLISH (70)

14.0% ROIC with 42.0% gross margin and 13.63% FCF yield.

SEC Forensic Auditor AI
10-K Accruals & Altman-Z Guard
NEUTRAL (65)

Altman-Z 4.20 and Piotroski 5/9 pass balance-sheet audit.

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
BEARISH (45)

18/40 institutional & smart-money positioning score with 9/20 macro alignment.

Bull Case: Why Buyers Like UROY
  • ✓Company leadership has skin in the game with net positive insider conviction.
Bear Case: What Could Go Wrong
  • !Sensitive to high interest rates and tighter Federal Reserve market liquidity.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring UROY)

  • ✓Walkthrough of UROY's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
UROY // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -12.07%📐 HORIZONTAL RANGE
2026-11-02O $3.57H $3.57L $3.35C $3.35VOL 2.39M
RES: $5.56SUP: $1.97SMA50: $4.06SMA200: $3.76
$5.15$4.45$3.75$3.04$2.34RES $5.56SUP $1.97$3.352026-05-042026-06-172026-08-042026-09-172026-11-02
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

UROY Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
25.1%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on UROY today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for UROY. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for UROY today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (UROY)

Financials Rank #582 of 1096 ⚔️ MUA vs UROY Full Matrix →

1. Head-to-Head Financials Peer Comparison (UROY vs. MUA, BKT, OPY, MUC)

Industry: Investment Bankers/Brokers/Service (64 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, Uranium Royalty Corp. (UROY) ranks #582 by composite RQD confidence (54/100, grade D+) and #512 by equity capitalization ($1.31B). Within this direct 5-issuer industry benchmark cohort, OPY leads on earnings valuation at 7.8x trailing P/E, while OPY leads on capital efficiency and profitability with 17.6% ROIC and — gross margin. OPY currently holds the highest overall quantitative score in the immediate peer group at 69/100 (C+) compared with UROY at 54/100 (D+).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
UROY ACTIVE
Uranium Royalty Corp.
D+ 54/100 32.5x — — -3.46% $1.31B Benchmark Subject
MUA
Blackrock MuniAssets Fund Inc
D 47/100 — — — +0.20% $1.45B /mua-vs-uroy →
BKT
BlackRock Income Trust Inc.
D 47/100 — — — -0.20% $1.47B /bkt-vs-uroy →
OPY
Oppenheimer Holdings Inc. (Class A)
C+ 69/100 7.8x — 17.6% -20.14% $1.16B /opy-vs-uroy →
MUC
Blackrock MuniHoldings California Quality Fund Inc.
D 47/100 — — — +0.60% $1.50B /muc-vs-uroy →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2026-04-30 • CIK 0002143673

In its most recent audited fiscal period (FY2025, filed 2026-04-30), Uranium Royalty Corp. (UROY) reported GAAP revenue of $0 (N/A vs. FY2024 revenue of $0 ) , GAAP net income of $40.2M, operating cash flow of $178.5M, and free cash flow of $178.5M (+1285.0% YoY). On the balance sheet, UROY closed FY2025 with $0 in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 5/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2026-04-30 $0 $40.2M $178.5M $178.5M — —
FY2024 (FY) 2025-04-30 $0 -$4.5M -$15.1M -$15.1M — —
FY2023 (FY) 2024-04-30 $0 $13.7M -$76.4M -$76.4M — —

3. UROY Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is UROY stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-02, Uranium Royalty Corp. (NASDAQ: UROY) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 54/100 at a spot price of $3.35 (-3.46% 1D, market cap $1.31B). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 4/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 14/20. Across 1096 tracked Financials issuers, UROY ranks #582 in composite RQD confidence.

How does UROY compare to MUA and BKT in the Financials sector?

Within the Financials sector (Investment Bankers/Brokers/Service), UROY carries a Roarable D+ (54/100 RQD), trailing P/E of 32.5x, gross margin of —, and ROIC of —. By comparison, MUA (Blackrock MuniAssets Fund Inc) holds a D grade (47/100 RQD, P/E N/A, ROIC —, cap $1.45B) and BKT (BlackRock Income Trust Inc.) posts a D grade (47/100 RQD, P/E N/A, ROIC —, cap $1.47B). Among the 5-stock peer group, OPY leads on earnings multiple (7.8x) while OPY leads on capital efficiency (17.6% ROIC).

What are the biggest fundamental strengths and SEC risk factors for UROY?

Per UROY's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-04-30, CIK 0002143673), Uranium Royalty Corp. generated $0 in revenue, $40.2M in net income, and $178.5M in free cash flow against $0 in total assets and $0 in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is UROY trading relative to its 50-day, 200-day, and 52-week technical levels?

UROY last traded at $3.35 (-3.46% on volume of 2,975,496 shares), positioning the stock -17.49% below its 50-day simple moving average ($4.06) and -10.90% below its 200-day simple moving average ($3.76). Across its 52-week range of $2.56 to $5.52, UROY sits at the 26.7% percentile with a 14-day RSI of 41.2 (NEUTRAL RANGE) and an implied next-earnings move of ±9.9% ($3.02 to $3.68).

UROY Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell UROY stock right now?

Uranium Royalty Corp. (UROY) currently earns a Roarable Rating of D+ (Sell — SELL) with 54/100 RQD Confidence. Stretched risk/reward at 33x P/E (steady margins) under elevated 10-year interest-rate pressure.

What is UROY's 12-month price target and RQD AI Jury consensus?

UROY's 12-month base price target is $3.29 (range $2.57 to $5.8), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

ROARABLE RATING BRIEF • RQD 54/100 (D+) ✓ STAGE-C NUMBER FIREWALL VERIFIED

UROY — Uranium Royalty Corp.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:29:41Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, UROY scores 54 out of 100, a letter grade of D+, with the verdict "Roarable Sell — Weak Fundamentals / Trim." The fundamental cash engine pillar scores 14 of 20, with ROIC at 0% and an FCF yield of 13.63%, which points to a cash-generation profile that is more meaningful than its accounting returns. The whale 13F flow pillar scores 4 of 20, indicating weak institutional accumulation and options positioning in the source data. The insider conviction pillar scores 14 of 20, reflecting SEC Form 4 and Congressional PTR cluster flow. The macro regime fit pillar scores 9 of 20, with a beta of 1.0 and sector sensitivity as the stated driver. The forensic balance sheet pillar scores 13 of 20, supported by an Altman Z-Score of 2.5, a Piotroski F-Score of 5/9, and a Debt/Equity ratio of 0.5.

For a prospective investor evaluating the stock today, the upside case rests mainly on the free-cash-flow yield and the FY 2025 FCF figure of $178.5M, which stands far above reported net income. The valuation tradeoff is significant: per the market data, the P/E (TTM) is 32.5 and EV/EBITDA is 27.1 against EPS (TTM) of 0.11, meaning the price embeds expectations well beyond current reported earnings. The low whale-flow score and the weak macro-fit score suggest limited institutional tailwind and above-market sensitivity. These are analytical observations from the rating framework, not a personalized recommendation.

Snapshot

PriceMarket CapP/E (TTM)Forward P/EEV/EBITDAEPS (TTM)Dividend YieldBeta52-Wk RangeROIC %
3.47$1.31B32.530.227.10.110%1.0$2.56 - $5.520%

Business

Uranium Royalty Corp. (UROY) is a NASDAQ-listed company classified in the Financials sector and the Investment Bankers/Brokers/Service industry, per the profile. Not available in source data for product lines, customer base, or revenue model detail. The reported revenue figures are $0.0M across all listed periods, per the SEC financials. Not available in source data for how the company makes money beyond the reported net income and FCF figures.

Financial Trend

PeriodRevenueOperating IncomeNet IncomeEPSFCFCashDebt
FY 2025$0.0M$48.3M$40.2MN/A$178.5MN/AN/A
FY 2024$0.0M$-3.4M$-4.5MN/A$-15.1MN/AN/A
FY 2023$0.0M$5.1M$13.7MN/A$-76.4MN/AN/A

Per the SEC financials, reported revenue is $0.0M in each period, while operating income was $48.3M in FY 2025 after losses in FY 2024 and positive results in FY 2023. Market data lists gross, operating, and net margins as 0%, and ROIC as 0%, so profitability cannot be assessed from margin figures in the source. Per the RQD forensic pillar, the Altman Z-Score is 2.5, the Piotroski F-Score is 5/9, and Debt/Equity is 0.5. Cash and debt balances are not available in source data.

Recent Catalysts & News Wire Analysis

Per <recent_news_and_catalysts>, the most recent items are headlines covering an equity shelf capacity expansion of US$916 Million, a note that the stock "Looks Fully Priced After A 30% Gain," an H.C. Wainwright reiteration of a buy rating, a TradingView estimates page, a MarketBeat consensus target item citing $4.12, and a Simply Wall St piece on whether the shelf registration changes the bull case. The shelf-expansion headline is the most material risk watch item, as it signals potential equity dilution capacity. The "fully priced" headline and the $4.12 consensus figure frame the valuation debate. The Butterfly Supply-Chain Graph reports no proprietary signals and no supply-chain links, so no proprietary signal read-through is available.

Butterfly Effect: 2nd-Order Supply-Chain & Sector Ripples

Per the Butterfly Supply-Chain Graph, supply chain status is NONE and no butterfly links are present. Not available in source data for upstream or downstream dependencies, sector correlations beyond the Financials classification, or second-order bottlenecks. A prospective investor should note that the absence of mapped links means ripple effects cannot be traced from the source data.

Open Questions

  • What is the company's revenue model, given reported revenue of $0.0M across all periods while net income was $40.2M in FY 2025?
  • What are the cash and debt balances, which are listed as N/A, needed to reconcile the $178.5M FY 2025 FCF with the Debt/Equity of 0.5?
  • What is the scale and timing of the US$916 Million equity shelf capacity, and how much dilution would it imply?
  • What drove the swing from FY 2024 losses to the FY 2025 operating income of $48.3M?
  • What is the source and composition of the institutional and insider flow behind the 4/20 whale-flow and 14/20 insider pillar scores?

UROY Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Uranium Royalty Corp. (UROY) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to UROY Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

UROY Bull vs. Bear Conversation Board — What's Your Call at $3.35?

🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON UROY 🐻 50% BEARISH CONVICTION
1. Pick Your Side on UROY:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST 🎯 Target: $3.75 (+8.1%)
📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is UROY (D+ • RQD 54/100) a Buy at $3.47?

Welcome to the UROY (Uranium Royalty Corp.) Roar Pit. Current RQD Composite is 54/100 (Roarable Sell — Weak Fundamentals / Trim) in Investment Bankers/Brokers/Service. Bulls point to operating leverage and sector positioning, while bears focus on valuation multiple compression (32.5x trailing P/E). Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

SH ShortSeller_Dan Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $2.71 (-21.9%)
Spot @ $3.47

Pump the brakes on UROY — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on UROY, but look at what you are paying: 32.5x trailing P/E with tightening sector spreads. Unless Uranium Royalty Corp. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

DE DeltaGamma_99 Verified K Arena Trader 🐂 BULLISH 🎯 Target: $3.99 (+15.0%)
Spot @ $3.47

UROY cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on UROY, the market is fixating on short-term headline noise in Investment Bankers/Brokers/Service and ignoring the balance sheet and cash flow trajectory. At $3.47 (52-wk range $2.56 - $5.52), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.36 -0.94% GLD $355.78 -1.34%